Browse > Article
http://dx.doi.org/10.12655/jkdoh.2013.9.1.36

DRUG INDUCED GINGIVAL HYPERPLASIA IN TAKAYASU'S ARTERITIS : DENTAL CONSIDERATION  

Kim, Soo-Hyun (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Choi, Ami (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Song, Je-Seon (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Kim, Seong-Oh (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Choi, Byung-Jai (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Lee, Hyo-Seol (Department of Pediatric Dentistry, College of Dentistry, Yonsei University)
Publication Information
The Journal of Korea Assosiation for Disability and Oral Health / v.9, no.1, 2013 , pp. 36-38 More about this Journal
Abstract
Takayasu's arteritis(TA) is commonly known as Aortitis Syndrome, Pulseless disease. Cardiac involvement due to vascular occlusion or stenosis is common in TA, expressed in forms of heart failure, aorta hypertension, alteration of artery or cardiac muscle. In this case, a 9 year old boy was referred to our dental clinic by his cardiology doctor for delayed eruption and gingival hyperplasia on upper incisor. The patient was diagnosed as TA with history of taking Amlodipine, a calcium channel blocker as hypertension medication. He was diagnosed as drug induced gingival hyperplasia. Under taking preventive antibiotic, gingivectomy was done. In case dental treatment of TA patient, dentist should be aware of two possible problems. First is the antibiotic prophylaxis due to the high risk of endocarditis. Second is the possibility of drug induced gingival hyperplasia.
Keywords
Takayasu's arteritis; Drug induced gingival hyperplasia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Al-Aghbari K, Al-Motarreb A, Askar F: Takayasu’s Arteritis Associated with Tuberculosis in a Young Yemeni Woman. Heart Views 11(3):117-120, 2010.   DOI   ScienceOn
2 Brunner J, Feldman BM, Tyrrell PN, et al.: Takayasu arteritis in children and adolescents. Rheumatology 49(10):1806-1814, 2010.   DOI   ScienceOn
3 Koide K: Takayasu arteritis in Japan. Heart and Vessels 7(1):48-54, 1992.   DOI
4 Dabague J, Reyes PA: Takayasu arteritis in Mexico: a 38-year clinical perspective through literature review. International journal of cardiology 54:S103-S109, 1996.   DOI   ScienceOn
5 Rosenthal T, Morag B, Itzchak Y: Takayasu arteritis in Israel. Heart and Vessels 7:44-47, 1992.   DOI
6 Butler R, Kalkwarf K, Kaldahl W: Drug-induced gingival hyperplasia: phenytoin, cyclosporine, and nifedipine. The Journal of the American Dental Association 114(1):56-60, 1987.   DOI
7 Seymour R, Thomason J, Ellis J: The pathogenesis of drug-induced gingival overgrowth. Journal of clinical periodontology 23(3):165-175, 1996.   DOI   ScienceOn
8 Brown RS, Beaver WT, Bottomley WK: On the mechanism of drug-induced gingival hyperplasia. Journal of oral pathology & medicine 20(5):201-209, 1991.   DOI   ScienceOn
9 Mehta AV, Chidambaram B, O’Riordan AC: Verapamil-induced gingival hyperplasia in children. American heart journal 124(2):535, 1992.   DOI   ScienceOn
10 Woods R, Amerena V, David P: FDI Commission Working Group: antibiotic prophylaxis for infective endocarditis. Int Dent J 44:215-222, 1994.
11 Dajani AS, Taubert KA, Wilson W, et al.: Prevention of bacterial endocarditis: recommendations by the American Heart Association. Circulation 96(1):358-366, 1997.   DOI   ScienceOn
12 Duque C, Silva RC, Santos-Pinto L: Takayasu's arteritis: what should the dentist know? Int J Paediatr Dent 15(2):113-117, 2005.   DOI   ScienceOn